Denis Bergeron received a B.S. in chemistry from Loyola University New Orleans and a Ph.D. in physical chemistry from the Pennsylvania State University. Following a postdoctoral fellowship at the University of Nottingham, he came to NIST as a National Research Council (NRC) Fellow in 2006 and joined the Radioactivity Group as a research chemist in 2008. His two daughters think a bowling analogy for targeted alpha therapy seems like a stretch.